Skip to main content
. 2015 Mar 23;4(3):e001624. doi: 10.1161/JAHA.114.001624

Figure 6.

Figure 6.

Relationships between plasma ELDP (A) and plasma CT‐proET‐1 (B) and urine sodium excretion following 6 weeks of treatment with sitaxentan. CT‐proET‐1 indicates C‐terminal pro‐endothelin‐1; ELDP, endothelin‐like domain peptide.